| Identification | Back Directory | [Name]
N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide | [CAS]
1071517-39-9 | [Synonyms]
ANA598
RG7790
RG-7790
ANA 598
CS-1474
Setrobuvir
RO-5466731
ANA598; ANA 598
Setrobuvir (ANA598)
N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiad
N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide
Methanesulfonamide, N-[3-[(4aR,5S,8R,8aS)-1-[(4-fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]- | [Molecular Formula]
C25H25FN4O6S2 | [MDL Number]
MFCD22124475 | [MOL File]
1071517-39-9.mol | [Molecular Weight]
560.62 |
| Hazard Information | Back Directory | [Uses]
Setrobuvir is an orally administered hepatitis C Virus non-??nucleoside analogue Inhibitor. Setrobuvir is an antiviral candidate for treating hepatitis E virus infection. |
| Spectrum Detail | Back Directory | [Spectrum Detail]
N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide(1071517-39-9)1HNMR
|
|
| Company Name: |
Cckinase, Inc.
|
| Tel: |
+1 (732)236-3202 |
| Website: |
www.cckinase.com |
|